Breaking News Instant updates and real-time market news.

PDD

Pinduoduo

$32.76

-0.85 (-2.53%)

, EXEL

Exelixis

$19.82

0.33 (1.69%)

07:35
09/03/19
09/03
07:35
09/03/19
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Friday in Pinduoduo (PDD), Exelixis (EXEL), and Stratasys (SSYS).

PDD

Pinduoduo

$32.76

-0.85 (-2.53%)

EXEL

Exelixis

$19.82

0.33 (1.69%)

SSYS

Stratasys

$23.81

0.28 (1.19%)

  • 07

    Sep

  • 09

    Sep

  • 27

    Sep

PDD Pinduoduo
$32.76

-0.85 (-2.53%)

08/22/19
KEYB
08/22/19
NO CHANGE
Target $40
KEYB
Overweight
Pinduoduo price target raised to $40 from $32 at KeyBanc
KeyBanc analyst Hans Chung raised his price target for Pinduoduo to $40 from $32 following "strong" quarterly results. The analyst expects the momentum to continue in the second half of the year given ramping customer acquisition on the Douyin platform, while anticipating more fierce competition in Q4 given 11.11 promotion.
08/19/19
LEHM
08/19/19
INITIATION
Target $32
LEHM
Overweight
Pinduoduo initiated with an Overweight at Barclays
Barclays analyst Gregory Zhao initiated Pinduoduo (PDD) with an Overweight rating and $32 price target, noting that the company has been able to break through the Alibaba (BABA) and JD.com (JD) duopoly to accumulate a sizeable user base with its unique team-buy, social marketplace model. He expects upside in its ARPU and take rate during its expansion into the high-end market, Zhao noted.
08/06/19
EGHT
08/06/19
DOWNGRADE
EGHT
Sell
Pinduoduo downgraded to Sell from Hold at 86 Research
08/22/19
BNCH
08/22/19
NO CHANGE
Target $39
BNCH
Buy
Pinduoduo price target raised to $39 from $28 at Benchmark
Benchmark analyst Fawne Jiang raised her price target on Pinduoduo shares to $39 from $28 after the company reported a "strong" revenue beat and EPS upside in Q2, stating that she is particularly encouraged by its reacceleration of user growth at lower S&M expenses. She is also positive on the company's strategic priority of gaining user's mindshare, said Jiang, who keeps a Buy rating on Pinduoduo shares.
EXEL Exelixis
$19.82

0.33 (1.69%)

07/15/19
PIPR
07/15/19
NO CHANGE
PIPR
Exelixis trial updates 'encouraging,' says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $45 price target on Exelixis, saying he is "confident" in CABO growth with net product sales forcast of $200M in Q2, $842M for FY19, and $1.08B in FY20. The analyst's note, titled Cabometyx I-O Combo Opportunity Grows in Phase Ib COSMIC-021 Study,' comes after the company announced new protocol updates to Phase Ib COSMIC-021 trial of Cabometyx + Tecentriq, which were spurred by "encouraging early efficacy and safety data in advanced NSCLC and mCRPC cohorts."
06/21/19
WBLR
06/21/19
NO CHANGE
WBLR
Outperform
William Blair an 'aggressive' buyer of Exelixis on weakness from clinical miss
William Blair analyst Andy Hsieh is an "aggressive" buyer of Exelixis (EXEL) shares on weakness after the company's partner Roche (RHHBY) informed the company that the Phase III IMspire170 trial, which assesses the safety and efficacy of the combination of Cotellic and Tecentriq, did not meet the primary endpoint of progression-free survival in treatment-naive melanoma. Hsieh says that while the news is disappointing, he reiterates that his bullish thesis resides in Exelixis's growth potential, driven by the Cabometyx franchise. As a result, the melanoma clinical setback does not impact the analyst's stock outlook. Further, he points out that he and the Street have not modeled revenue contribution from the IMspire170 study. Hsieh keeps an Outperform rating on Exelixis.
06/18/19
RHCO
06/18/19
DOWNGRADE
Target $48
RHCO
Hold
Array BioPharma downgraded to Hold from Buy at SunTrust
SunTrust analyst Peter Lawson downgraded Array BioPharma (ARRY) to Hold but raised his price target to $48 from $32 after the company announced that it is being acquired by Pfizer (PFE) at that price. The analyst notes that the 79% premium to the company's last closing price looks like a "fair valuation" based on his analysis of past comps and his M&A valuation model. Lawson adds that the the deal is "encouraging" within the biotech space with positive implications for other potential acquisition targets such as Agios Pharmaceuticals (AGIO) and Mirati herapeutics (MRTX) along with companies with strong chemistry such Incyte Corporation (INCY) and Exelixis (EXEL).
06/17/19
STFL
06/17/19
NO CHANGE
STFL
Stifel would be surprised if another suitor tries to outbid Pfizer for Array
After Pfizer (PFE) announced an agreement to acquire Array BioPharma (ARRY) for $48 per share in cash, Stifel analyst Stephen Willey said he views the deal as a "fitting," "logical" and "appropriate" conclusion for Array shareholders and he would be "very surprised" if another suitor tried to compete with a higher priced offer. He believes a "very fair valuation" is implied by the $11.4B price Pfizer has agreed to pay, Willey added. He also sees the deal announcement providing a tailwind for the sector, specifically for small-to-mid cap oncology companies that are "perceived to have achieved some meaningful level of de-risking." As examples, he offers Exelixis (EXEL) and Blueprint Medicines (BPMC), though Willey added that a potentially shortened exclusivity runway could make a deal for Exelixis "a bit harder for a strategic to rationalize."
SSYS Stratasys
$23.81

0.28 (1.19%)

08/05/19
SUSQ
08/05/19
NO CHANGE
Target $29
SUSQ
Positive
Stratasys results soft but shares remain attractive, says Susquehanna
Susquehanna analyst David Ryzhik said Stratasys Q2 results were disappointing but said the softness was not a surprise given softening Eurozone PMI's, weaker automobile industry data points, and recent commentary from peers in the industrial space. The analyst said despite the weakness, he remains positive on the shares at current levels in the context of an achievable growth acceleration. He also sees Stratasys as an attractive takeover target given its leadership position, strong balance sheet,, and rising high margin revenue stream. Ryzhik reiterated his Positive rating and raised is price target to $29 from $28 on Stratasys shares.
08/08/19
JPMS
08/08/19
DOWNGRADE
Target $7
JPMS
Underweight
JPMorgan downgrades 3D Systems to Underweight on 'gloomy' narrative
JPMorgan analyst Paul Coster downgraded 3D Systems (DDD) to Underweight from Neutral and lowered his price target for the shares to $7 from $8. The stock in premarket trading is down 9%, or 74c, to $7.41. The company posted "mixed" Q2 results and management's narrative "was gloomy" owing to weakness in the autos sector, lumpy ordering of a large enterprise customer, and a pause in metal systems sales, Coster tells investors in a research note. After reviewing the results, the analyst sees no reason for 3D Systems to trade at a premium to peer Stratasys (SSYS).
07/31/19
PIPR
07/31/19
NO CHANGE
Target $32
PIPR
Overweight
Piper remains optimistic despite Q2 revenue miss from Stratasys
Stratasys reported a Q2 revenue miss due to a significant drop in system demand, specifically in Europe, Piper Jaffray analyst Troy Jensen tells investors in a research note. Despite the miss, the analyst remains optimistic that product revenue will reaccelerate in 2020 given the launch of new systems and new material introductions. As a results, he reiterates an Overweight rating on Stratasys with a $32 price target.
08/01/19
08/01/19
NO CHANGE

Underperform
Stratasys shares have 'material downside' risk, says William Blair
Stratasys shares, at around $28, continue to be overvalued, William Blair analyst Brian Drab tells investors in a research note. The analyst now forecasts the company's organic revenue to be roughly flat in 2019 following the revenue shortfall in Q2. Further, he believes Stratasys' guidance looks aggressive. Drab sees "material downside in the stock" from the current level and maintains an Underperform rating on the name.

TODAY'S FREE FLY STORIES

AKAM

Akamai

$90.95

-0.13 (-0.14%)

21:13
09/18/19
09/18
21:13
09/18/19
21:13
Downgrade
Akamai rating change  »

Akamai downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

DB

Deutsche Bank

$8.06

-0.125 (-1.53%)

20:32
09/18/19
09/18
20:32
09/18/19
20:32
Hot Stocks
Deutsche Bank lowers prime lending rate to 5.00% from 5.25% »

Deutsche Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRVB

Provention Bio

$9.70

0.33 (3.52%)

20:31
09/18/19
09/18
20:31
09/18/19
20:31
Syndicate
Provention Bio 5M share Spot Secondary priced at $8.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 19

    Sep

DRI

Darden

$127.40

1.31 (1.04%)

20:25
09/18/19
09/18
20:25
09/18/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

XGN

Exagen

$0.00

(0.00%)

19:48
09/18/19
09/18
19:48
09/18/19
19:48
Syndicate
Exagen 3.6M share IPO priced at $14.00 »

The deal priced at low…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

PING

Ping Identity

$0.00

(0.00%)

19:35
09/18/19
09/18
19:35
09/18/19
19:35
Syndicate
Ping Identity 12.5M share IPO priced at $15.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CBS

CBS

$43.38

0.08 (0.18%)

, T

AT&T

$36.77

-0.39 (-1.05%)

19:04
09/18/19
09/18
19:04
09/18/19
19:04
Periodicals
Viacom, CBS, WarnerMedia pull e-cigarette ads from networks, CNBC says »

CBS (CBS),…

CBS

CBS

$43.38

0.08 (0.18%)

T

AT&T

$36.77

-0.39 (-1.05%)

VIA

Viacom

$27.94

-0.06 (-0.21%)

VIAB

Viacom

$25.77

0.02 (0.08%)

BTI

British American Tobacco

$36.90

0.06 (0.16%)

MO

Altria Group

$40.84

-0.47 (-1.14%)

PM

Philip Morris

$71.58

-0.4 (-0.56%)

IMBBY

Imperial Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 12

    Nov

CRON

Cronos Group

$10.96

-0.205 (-1.84%)

18:57
09/18/19
09/18
18:57
09/18/19
18:57
Hot Stocks
Cronos Group CEO: We focus on supply and the consumer »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

$44.48

-0.02 (-0.04%)

, SVRA

Savara

$2.49

-0.14 (-5.32%)

18:46
09/18/19
09/18
18:46
09/18/19
18:46
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

MLHR

Herman Miller

$44.48

-0.02 (-0.04%)

SVRA

Savara

$2.49

-0.14 (-5.32%)

CBPO

China Biologic

$103.19

0.37 (0.36%)

NCR

NCR Corp.

$33.62

0.77 (2.34%)

MSFT

Microsoft

$138.53

1.13 (0.82%)

TNDM

TNDM

X

U.S. Steel

$12.45

-0.51 (-3.94%)

PRVB

Provention Bio

$9.70

0.33 (3.52%)

PAA

Plains All American

$21.87

-0.315 (-1.42%)

COST

Costco

$292.47

0.96 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 23

    Sep

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 21

    Oct

  • 22

    Oct

  • 27

    Oct

  • 05

    Nov

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

TECD

Tech Data

$103.32

-0.59 (-0.57%)

18:41
09/18/19
09/18
18:41
09/18/19
18:41
Hot Stocks
Tech Data CEO: We are confident in our company and where we are going »

Tech Data CEO Richard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$36.77

-0.39 (-1.05%)

, DISH

Dish

$35.58

0.3 (0.85%)

18:34
09/18/19
09/18
18:34
09/18/19
18:34
Periodicals
AT&T, Dish not in discussions over DirecTV deal, Reuters reports »

AT&T (T) and Dish…

T

AT&T

$36.77

-0.39 (-1.05%)

DISH

Dish

$35.58

0.3 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Oct

AGCO

Agco

$76.04

-0.16 (-0.21%)

18:30
09/18/19
09/18
18:30
09/18/19
18:30
Hot Stocks
Agco CEO: We are on schedule in the U.S. »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$14.63

-0.31 (-2.08%)

18:22
09/18/19
09/18
18:22
09/18/19
18:22
Periodicals
Petrobras raises gasoline, diesel prices in wake of Saudi attacks, Reuters says »

Petrobras has boosted the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$123.69

-0.28 (-0.23%)

18:01
09/18/19
09/18
18:01
09/18/19
18:01
Hot Stocks
Celanese increases Vinyl Acetate Monomer price in EMEA by EUR50/MT »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STI

SunTrust

$68.57

0.48 (0.70%)

18:00
09/18/19
09/18
18:00
09/18/19
18:00
Hot Stocks
SunTrust lowers prime lending rate to 5% from 5.25% »

Following the Federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBS

Webster Financial

$48.84

0.43 (0.89%)

17:53
09/18/19
09/18
17:53
09/18/19
17:53
Hot Stocks
Webster Financial lowers prime lending rate to 5.0% from 5.25% 

Effective September 19.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 13

    Nov

HSBC

HSBC

$38.19

-0.1 (-0.26%)

17:52
09/18/19
09/18
17:52
09/18/19
17:52
Hot Stocks
HSBC decreases prime lending rate to 5% from 5.25% »

HSBC Bank USA and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

HES

Hess Corp.

$66.91

-0.92 (-1.36%)

17:50
09/18/19
09/18
17:50
09/18/19
17:50
Hot Stocks
Hess Corp. COO sells 17,750 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

CSCO

Cisco

$49.32

-0.1 (-0.20%)

, DDOG

Datadog

$0.00

(0.00%)

17:46
09/18/19
09/18
17:46
09/18/19
17:46
Periodicals
Cisco approached Datadog with $7B+ takeover bid, Bloomberg says »

Cisco (CSCO) approached…

CSCO

Cisco

$49.32

-0.1 (-0.20%)

DDOG

Datadog

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

  • 13

    Nov

  • 19

    Sep

ASB

Associated Banc-Corp

$20.23

0.075 (0.37%)

17:46
09/18/19
09/18
17:46
09/18/19
17:46
Hot Stocks
Associated Banc-Corp lowers prime rate to 5.0% from 5.25% 

Effective September 19.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Shares

$140.69

-0.93 (-0.66%)

17:45
09/18/19
09/18
17:45
09/18/19
17:45
Hot Stocks
SPDR Gold Shares holdings rise to 883.60MT from 880.37MT »

This is the second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$36.77

-0.39 (-1.05%)

, DISH

Dish

$35.58

0.3 (0.85%)

17:44
09/18/19
09/18
17:44
09/18/19
17:44
Periodicals
AT&T exploring options to part with DirecTV unit, WSJ says »

AT&T (T) is looking…

T

AT&T

$36.77

-0.39 (-1.05%)

DISH

Dish

$35.58

0.3 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Oct

CBPO

China Biologic

$103.19

0.37 (0.36%)

17:43
09/18/19
09/18
17:43
09/18/19
17:43
Hot Stocks
China Biologic up 7% after receiving 'going private' proposal for $120 per share »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$36.77

-0.39 (-1.05%)

, DISH

Dish

$35.58

0.3 (0.85%)

17:42
09/18/19
09/18
17:42
09/18/19
17:42
Hot Stocks
AT&T, Dish move higher after WSJ report that AT&T has explored DirecTV options »

Shares of both AT&T…

T

AT&T

$36.77

-0.39 (-1.05%)

DISH

Dish

$35.58

0.3 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Oct

GSK

GlaxoSmithKline

$41.06

-0.04 (-0.10%)

17:41
09/18/19
09/18
17:41
09/18/19
17:41
Periodicals
FDA panel recommends approval of GSK's nicotine oral spray, Reuters says »

An independent expert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 24

    Sep

  • 27

    Sep

  • 02

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.